NCT05977803View on ClinicalTrials.gov

Contribution of the CEST Sequence in the Characterization of Radionecrosis of Brain Metastases of Pulmonary Origin

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 15, 2024

Primary Completion Date

February 15, 2026

Study Completion Date

February 15, 2027

Conditions
Brain MetastasesRadionecrosisPulmonary Cancer
Interventions
RADIATION

MRI with CEST sequence, IVIM and ASL sequence

"Three sequences will be added as part of the protocol (for an additional duration of about 10 minutes) :~* The CEST sequence~* The ASL infusion sequence~* The IVIM sequence"

Trial Locations (1)

75018

RECRUITING

Hôpital Bichat-Claude Bernard, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER